Analysts think MURA stock price could increase by 500%
Apr 15, 2025, 11:25 AM
154.90%
What does MURA do
Mural Oncology Plc is a clinical-stage company developing cytokine-based immunotherapies for cancer using its protein engineering platform. Its portfolio includes Nemvaleukin alfa and a tumor-targeted split IL-12 program.
4 analysts think MURA stock price will increase by 500.00%. The current median analyst target is $6.12 compared to a current stock price of $1.02. The lowest analysts target is $6.06 and the highest analyst target is $6.30.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
